Your browser doesn't support javascript.
loading
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120).
Khan, Rashid; Dhodapkar, Madhav; Rosenthal, Adam; Heuck, Christoph; Papanikolaou, Xenofon; Qu, Pingping; van Rhee, Frits; Zangari, Maurizio; Jethava, Yogesh; Epstein, Joshua; Yaccoby, Shmuel; Hoering, Antje; Crowley, John; Petty, Nathan; Bailey, Clyde; Morgan, Gareth; Barlogie, Bart.
Afiliação
  • Khan R; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Dhodapkar M; Yale School of Medicine, New Haven, CT, USA.
  • Rosenthal A; Cancer Research And Biostatistics, Seattle, WA, USA.
  • Heuck C; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Papanikolaou X; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Qu P; Cancer Research And Biostatistics, Seattle, WA, USA.
  • van Rhee F; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Zangari M; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Jethava Y; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Epstein J; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Yaccoby S; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Hoering A; Cancer Research And Biostatistics, Seattle, WA, USA.
  • Crowley J; Cancer Research And Biostatistics, Seattle, WA, USA.
  • Petty N; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Bailey C; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Morgan G; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Barlogie B; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA bart.barlogie@mssm.edu.
Haematologica ; 100(9): 1214-21, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26022710
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Instabilidade Genômica / Genes Neoplásicos / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Haematologica Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Instabilidade Genômica / Genes Neoplásicos / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Haematologica Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos